Evidence map›Paper›PMID 35241475›Full record

Observational studyBMJ open2022

Patient journey during and after a pre-eclampsia-complicated pregnancy: a cross-sectional patient registry study.

Rianne C Bijl, Sophie E Bangert, Raj Shree, Alina N Brewer, Norlisa Abrenica-Keffer, Eleni Z Tsigas, Maria P H Koster, Ellen W Seely

Registry-linked trialOpen access · goldAbstract readObservational Study
PubMed Full text at PMC Publisher
In one paragraph

Observational study in BMJ open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02020174, which is not on this map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02020174 no registry record found
3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. AβJournal of molecular histology · 2024
    Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Rianne C BijlDepartment of Obstetrics and Gynaecology, Erasmus University Medical Centre, Rotterdam, The Netherlands.ORCID 0000-0002-0914-3206
Sophie E BangertDepartment of Obstetrics and Gynaecology, Erasmus University Medical Centre, Rotterdam, The Netherlands.
Raj ShreeDepartment of Obstetrics and Gynecology, University of Washington, Seattle, Washington, USA.ORCID 0000-0002-2747-2097
Alina N BrewerPreeclampsia Foundation, Melbourne, Florida, USA.
Norlisa Abrenica-KefferPreeclampsia Foundation, Melbourne, Florida, USA.
Eleni Z TsigasPreeclampsia Foundation, Melbourne, Florida, USA.
Maria P H KosterDepartment of Obstetrics and Gynaecology, Erasmus University Medical Centre, Rotterdam, The Netherlands.
Ellen W SeelyDepartment of Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA ESEELY@bwh.harvard.edu.ORCID 0000-0002-4425-1878
Erasmus University Rotterdam · NLPreeclampsia Foundation · USBrigham and Women's Hospital · USUniversity of Washington · US

Funding

Cardiovascular disease, preeclampsia, and microchimerismK08HL150169 · NHLBI · UNIVERSITY OF WASHINGTON · PI SHREE, RAJ · 2020 to 2024
$816k
NHLBI NIH HHS K08 HL150169
6 · The paper itself

Abstract

objectivesTo gain insight into the patient journey through a pre-eclampsia-complicated pregnancy.

designCross-sectional patient registry study.

settingOnline patient registry initiated by the Preeclampsia Foundation.

participantsWomen with a history of pre-eclampsia enrolled in The Preeclampsia Registry (TPR). PRIMARY AND SECONDARY OUTCOME MEASURES: Retrospective patient-reported experience measures concerning awareness of pre-eclampsia, timing and type of information on pre-eclampsia received, involvement in decision making regarding medical care, mental/emotional impact of the pre-eclampsia-complicated pregnancy and impact on future pregnancy planning.

resultsOf 3618 TPR-participants invited to complete the Patient Journey questionnaire, data from 833 (23%) responders were available for analysis. Most responders were white (n=795, 95.4%) and lived in the USA (n=728, 87.4%). Before their pre-eclampsia diagnosis, 599 (73.9%) responders were aware of the term 'pre-eclampsia', but only 348 (43.7%) were aware of its associated symptoms. Women with a lower level of education were less likely to have heard of pre-eclampsia (OR 0.36, 95% CI 0.21 to 0.62). Around the time of diagnosis, 29.2% of responders did not feel involved in the decision making, which was associated with reporting a serious mental/emotional impact of the pre-eclampsia experience (OR 2.46, 95% CI 1.58 to 3.84). Over time, there was an increase in the proportion of women who were aware of the symptoms of pre-eclampsia (32.2% before 2011 to 52.5% after 2016; p<0.001) and in the proportion of responders stating they received counselling about the later-life health risks associated with pre-eclampsia (14.2% before 2011 to 25.6% after 2016; p=0.005).

conclusionsThis study demonstrates that improved patient education regarding pre-eclampsia is needed, that shared decision making is of great importance to patients to enhance their healthcare experience, and that healthcare providers should make efforts to routinely incorporate counselling about the later-life health risks associated with pre-eclampsia. TRIAL REGISTRATION NUMBER: NCT02020174.

Indexed as

Pre-EclampsiaCounselingCross-Sectional StudiesFemaleHumansPregnancyRegistriesRetrospective Studieshypertensionmaternal medicinemental healthquality in health care

Identifiers

PMID35241475
PMCPMC8896051
OpenAlexW4214896451

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.